Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow JonesDow Jones2026/08/21 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. rose 6.2% to $8.94 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.

Novavax Inc. closed 25.3% short of its 52-week high of $11.97, which the company reached on February 26th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Merck & Co. Inc. rose 2.39% to $152.55.

Trading volume totaled 10.4 million, compared to the 50-day average of 3.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 21, 2026 16:33 ET (20:33 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!